240 related articles for article (PubMed ID: 16528993)
1. [Treatment for perioperative arrhythmias with nifekalant hydrochloride].
Nishida M; Okada H; Murakami M; Hamano K
Kyobu Geka; 2006 Mar; 59(3):210-3. PubMed ID: 16528993
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
[TBL] [Abstract][Full Text] [Related]
3. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
Morita N; Tanaka K; Yodogawa K; Hayashi M; Akutsu K; Yamamoto T; Satoh N; Kobayashi Y; Katoh T; Takano T
Pacing Clin Electrophysiol; 2007 Oct; 30(10):1242-53. PubMed ID: 17897127
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic effect of nifekalant on atrial tachyarrhythmia in four patients with severe heart failure.
Shiga T; Matsuda N; Fuda Y; Haruta S; Hagiwara N; Kasanuki H
J Cardiol; 2002 Mar; 39(3):159-64. PubMed ID: 11912950
[TBL] [Abstract][Full Text] [Related]
5. Prevention of life-threatening ventricular tachyarrhythmia by a novel and pure class-III agent, nifekalant hydrochloride.
Ohashi J; Yasuda S; Miyazaki S; Shimizu W; Morii I; Kurita T; Kawamura A; Kamakura S; Nonogi H
J Cardiovasc Pharmacol; 2006 Dec; 48(6):274-9. PubMed ID: 17204905
[TBL] [Abstract][Full Text] [Related]
6. [The efficiency of nifekalant hydrochloride for the prevention of ventricular tachycardia during cardiac surgery].
Sakaguchi M; Takemura T; Shimamura Y; Tsuda Y; Iwasa S
Kyobu Geka; 2004 Mar; 57(3):191-5. PubMed ID: 15035072
[TBL] [Abstract][Full Text] [Related]
7. Nifekalant versus lidocaine for in-hospital shock-resistant ventricular fibrillation or tachycardia.
Shiga T; Tanaka K; Kato R; Amino M; Matsudo Y; Honda T; Sagara K; Takahashi A; Katoh T; Urashima M; Ogawa S; Takano T; Kasanuki H;
Resuscitation; 2010 Jan; 81(1):47-52. PubMed ID: 19913983
[TBL] [Abstract][Full Text] [Related]
8. [Nifekalant hydrochloride as an effective treatment for postoperative ischemic heart disease].
Enomoto Y; Aoki K; Toshimitsu Y; Inai Y; Asakura T; Furuta S
Kyobu Geka; 2005 Apr; 58(4):316-9. PubMed ID: 15828253
[TBL] [Abstract][Full Text] [Related]
9. [Nifekalant hydrochloride effective against perioperative ventricular tachycardia in patients with impaired left ventricular function].
Murakami T; Makino Y; Kato H
Kyobu Geka; 2007 Jun; 60(6):469-73. PubMed ID: 17564063
[TBL] [Abstract][Full Text] [Related]
10. [Successful administration of nifekalant hydrochloride for postoperative junctional ectopic tachycardia in congenital cardiac surgery].
Sasaki T; Nemoto S; Ozawa H; Katsumata T; Ozaki N; Okumura K; Katayama H; Tamai H; Kishida H
Kyobu Geka; 2007 Oct; 60(11):1022-6. PubMed ID: 17926908
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience with intravenous administration of nifekalant hydrochloride for ventricular tachycardia in a hemodialysis patient after open heart surgery].
Furukawa H; Aono H; Samukawa M; Iwasaki K; Ohkado A
Kyobu Geka; 2010 Oct; 63(11):988-91. PubMed ID: 20954355
[TBL] [Abstract][Full Text] [Related]
12. Nifekalant hydrochloride terminating sustained ventricular tachycardia accompanied with QT dispersion prolongation.
Wang J; Hua W; Zhu J; Yang YM; Wang FZ; Pu JL; Chen KP; Zhang S
Chin Med J (Engl); 2010 Aug; 123(15):2028-33. PubMed ID: 20819537
[TBL] [Abstract][Full Text] [Related]
13. Advanced cardiac life support controversy: where do antiarrhythmic agents fit in?
Chow MS
Pharmacotherapy; 1997; 17(2 Pt 2):84S-88S; discussion 89S-91S. PubMed ID: 9085344
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Yusu S; Ikeda T; Mera H; Miyakoshi M; Miwa Y; Abe A; Tsukada T; Ishiguro H; Shimizu H; Yoshino H
Circ J; 2009 Nov; 73(11):2021-8. PubMed ID: 19724153
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of nifekalant hydrochloride in the treatment of fatal ventricular arrhythmia in patients with ischemic heart disease.
Ando J; Kakishita M; Sakai K; Komura Y; Nishiyama K; Iwabuchi M; Yokoi H; Yasumoto H; Nosaka H; Nobuyoshi M
Int Heart J; 2005 Jul; 46(4):647-56. PubMed ID: 16157956
[TBL] [Abstract][Full Text] [Related]
16. Emergency treatment with nifekalant, a novel class III anti-arrhythmic agent, for life-threatening refractory ventricular tachyarrhythmias: post-marketing special investigation.
Katoh T; Mitamura H; Matsuda N; Takano T; Ogawa S; Kasanuki H
Circ J; 2005 Oct; 69(10):1237-43. PubMed ID: 16195624
[TBL] [Abstract][Full Text] [Related]
17. [Management of lethal ventricular arrhythmias after cardiac surgery].
Ohnishi S
Nihon Rinsho; 2002 Jul; 60(7):1440-8. PubMed ID: 12136627
[TBL] [Abstract][Full Text] [Related]
18. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
Klein G; Lissel C; Fuchs AC; Gardiwal A; Oswald H; Desousa M; Pichlmaier AM; Lichtinghagen R; Geerlings H; Lippolt P; Niehaus M; Drexler H; Korte T
Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
[TBL] [Abstract][Full Text] [Related]
19. Management of ventricular arrhythmias.
Aronow WS
Compr Ther; 2008; 34(2):89-99. PubMed ID: 18833785
[TBL] [Abstract][Full Text] [Related]
20. Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.
Goldsmith YB; Liu J; Chou J; Hoffman J; Comenzo RL; Steingart RM
Am J Cardiol; 2009 Oct; 104(7):990-4. PubMed ID: 19766769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
